Registry Search

TEMSIROLIMUS

Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hyperglycemia and interstitial lung disease.

TEN-K

Comprehensive clinical and safety monograph for TEN-K (TEN-K).

TENATHAN

Comprehensive clinical and safety monograph for TENATHAN (TENATHAN).

TENCON

Comprehensive clinical and safety monograph for TENCON (TENCON).

TENEX

Comprehensive clinical and safety monograph for TENEX (TENEX).

TENOFOVIR ALAFENAMIDE

Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.

TENOFOVIR ALAFENAMIDE FUMARATE

Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.

TENOFOVIR DISOPROXIL FUMARATE

Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.

Tenofovir-Lamivudine-Efavirenz

Standard first-line ART for HIV-positive pregnant women per WHO 2021 guidelines. Tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) + efavirenz (EFV) as a fixed-dose combination. Efavirenz was historically avoided in T1 due to neural tube defect risk in animal studies; large human registry data (>2,000 T1 exposures) have not confirmed this risk in humans. WHO and UNAIDS now endorse EFV-based regimens throughout pregnancy. Starting or continuing ART is critical to prevent mother-to-child transmission (MTCT) of HIV — benefits far outweigh any theoretical risks.

TENORETIC 100

Comprehensive clinical and safety monograph for TENORETIC 100 (TENORETIC 100).

TENORETIC 50

Comprehensive clinical and safety monograph for TENORETIC 50 (TENORETIC 50).

TENORMIN

Comprehensive clinical and safety monograph for TENORMIN (TENORMIN).

TENSILON

Comprehensive clinical and safety monograph for TENSILON (TENSILON).

TENSILON PRESERVATIVE FREE

Comprehensive clinical and safety monograph for TENSILON PRESERVATIVE FREE (TENSILON PRESERVATIVE FREE).

TENUATE

Comprehensive clinical and safety monograph for TENUATE (TENUATE).

TENUATE DOSPAN

Comprehensive clinical and safety monograph for TENUATE DOSPAN (TENUATE DOSPAN).

TEPADINA

Comprehensive clinical and safety monograph for TEPADINA (TEPADINA).

TEPADINA AND SODIUM CHLORIDE

No significant drug interactions Can cause hypernatremia and fluid overload.

TEPANIL

Comprehensive clinical and safety monograph for TEPANIL (TEPANIL).

TEPANIL TEN-TAB

Comprehensive clinical and safety monograph for TEPANIL TEN-TAB (TEPANIL TEN-TAB).

TEPEZZA

Comprehensive clinical and safety monograph for TEPEZZA (TEPEZZA).

TEPMETKO

Comprehensive clinical and safety monograph for TEPMETKO (TEPMETKO).

TEPYLUTE

Comprehensive clinical and safety monograph for TEPYLUTE (TEPYLUTE).

TERAZOL 3

Comprehensive clinical and safety monograph for TERAZOL 3 (TERAZOL 3).

TERAZOL 7

Comprehensive clinical and safety monograph for TERAZOL 7 (TERAZOL 7).

TERAZOSIN HYDROCHLORIDE

Other antihypertensive drugs can have additive effects Can cause marked first-dose hypotension and syncope.

TERCONAZOLE

No significant drug interactions For vaginal use only can cause vulvovaginal burning.

TERFONYL

Comprehensive clinical and safety monograph for TERFONYL (TERFONYL).

TERIFLUNOMIDE

Comprehensive clinical and safety monograph for TERIFLUNOMIDE (TERIFLUNOMIDE).

TERIPARATIDE

No significant drug interactions Can cause orthostatic hypotension and increased risk of osteosarcoma.

TERLIVAZ

Comprehensive clinical and safety monograph for TERLIVAZ (TERLIVAZ).

TERRA-CORTRIL

Comprehensive clinical and safety monograph for TERRA-CORTRIL (TERRA-CORTRIL).

TERRAMYCIN

Comprehensive clinical and safety monograph for TERRAMYCIN (TERRAMYCIN).

TERRAMYCIN W/ POLYMYXIN

Comprehensive clinical and safety monograph for TERRAMYCIN W/ POLYMYXIN (TERRAMYCIN W/ POLYMYXIN).

TERRAMYCIN W/ POLYMYXIN B SULFATE

Comprehensive clinical and safety monograph for TERRAMYCIN W/ POLYMYXIN B SULFATE (TERRAMYCIN W/ POLYMYXIN B SULFATE).

TERRAMYCIN-POLYMYXIN

Comprehensive clinical and safety monograph for TERRAMYCIN-POLYMYXIN (TERRAMYCIN-POLYMYXIN).

TESLAC

Comprehensive clinical and safety monograph for TESLAC (TESLAC).

TESLASCAN

Comprehensive clinical and safety monograph for TESLASCAN (TESLASCAN).

TESSALON

Comprehensive clinical and safety monograph for TESSALON (TESSALON).

TESTIM

Comprehensive clinical and safety monograph for TESTIM (TESTIM).

TESTODERM

Comprehensive clinical and safety monograph for TESTODERM (TESTODERM).

TESTODERM TTS

Comprehensive clinical and safety monograph for TESTODERM TTS (TESTODERM TTS).

TESTOPEL

Comprehensive clinical and safety monograph for TESTOPEL (TESTOPEL).

TESTOSTERONE CYPIONATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

TESTOSTERONE ENANTHATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

TESTOSTERONE PROPIONATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

TESTOSTERONE UNDECANOATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

TESTRED

Comprehensive clinical and safety monograph for TESTRED (TESTRED).